Menarini Group y Radius Health presentan una solicitud de nuevo fármaco para elacestrant ...Middle East

PR Newswire - News
Menarini Group y Radius Health presentan una solicitud de nuevo fármaco para elacestrant
Menarini Group y Radius Health presentan una solicitud de nuevo fármaco a la FDA de Estados Unidos para elacestrant Diseñado para el tratamiento potencial de pacientes con cáncer de mama avanzado o metastásico ER+/HER2- Revisión prioritaria solicitada; si se acepta, anticipar una revisión...

Hence then, the article about menarini group y radius health presentan una solicitud de nuevo farmaco para elacestrant was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Menarini Group y Radius Health presentan una solicitud de nuevo fármaco para elacestrant )

Apple Storegoogle play

Last updated :

Also on site :